| __timestamp | BioCryst Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51796000 | 10117774 |
| Thursday, January 1, 2015 | 72758000 | 11801342 |
| Friday, January 1, 2016 | 61008000 | 11369941 |
| Sunday, January 1, 2017 | 66962000 | 11375237 |
| Monday, January 1, 2018 | 84888000 | 19919204 |
| Tuesday, January 1, 2019 | 107068000 | 18842752 |
| Wednesday, January 1, 2020 | 122964000 | 16496715 |
| Friday, January 1, 2021 | 208808000 | 16936000 |
| Saturday, January 1, 2022 | 253297000 | 19789000 |
| Sunday, January 1, 2023 | 216566000 | 93150000 |
Igniting the spark of knowledge
In the competitive world of biopharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, BioCryst Pharmaceuticals, Inc. has consistently outpaced Catalyst Pharmaceuticals, Inc. in R&D investments. From 2014 to 2023, BioCryst's R&D expenses surged by approximately 318%, peaking in 2022. In contrast, Catalyst's R&D spending grew by about 820% during the same period, albeit from a much smaller base. This strategic focus on R&D highlights the differing approaches of these two companies. BioCryst's steady increase in R&D spending underscores its long-term commitment to developing groundbreaking therapies, while Catalyst's recent spike in 2023 suggests a renewed focus on innovation. As the biopharma landscape evolves, these strategic investments will likely play a pivotal role in shaping the future of both companies.
Analyzing R&D Budgets: Amgen Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: argenx SE vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development Investment: Ascendis Pharma A/S vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Invests More in Innovation?
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: MannKind Corporation vs BioCryst Pharmaceuticals, Inc.